Challenges to research and innovation to optimize deceased donor organ quality and quantity

Am J Transplant. 2013 Jun;13(6):1400-4. doi: 10.1111/ajt.12243. Epub 2013 Apr 25.


Solid organ transplantation is encumbered by an increasing number of waitlisted patients unrequited by the current organ supply. Preclinical models suggest that advances in deceased donor management and treatment can increase the quantity and quality of organs available for transplantation. However, the science of donor intervention and the execution of high quality, prospective, multi-center, randomized-controlled trials are restricted by a myriad of logistical challenges mired in regulatory and ethical ambiguity. By highlighting the obstacles to conducting research in deceased donors, this report endeavors to stimulate the creation of a multi-disciplinary framework to facilitate the design, implementation and supervision of innovative trials that increase the quantity and/or quality of deceased donor organs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomedical Research*
  • Humans
  • Organ Transplantation / statistics & numerical data*
  • Tissue Donors / supply & distribution*
  • Tissue and Organ Procurement / standards*